For Patients & General Readers
Sickle Cell Disease is a group of inherited blood disorders that affect red blood cells. In this condition, red blood cells are abnormally shaped like a sickle or crescent moon, making it harder for them to travel through blood vessels. This can lead to pain, organ damage, and other serious health problems, primarily affecting individuals of African, Mediterranean, Middle Eastern, and South Asian descent.
Clinical Overview
Sickle Cell Disease (SCD) is a monogenic autosomal recessive disorder caused by a point mutation in the beta-globin gene, resulting in the production of abnormal hemoglobin S (HbS). HbS polymerizes under deoxygenated conditions, leading to rigid, sickle-shaped erythrocytes that cause chronic hemolysis and vaso-occlusion, manifesting in a wide spectrum of clinical complications.
Clinical Presentation
- Vaso-occlusive crises (VOCs) causing severe pain, most commonly in the bones, chest, and abdomen.
- Chronic hemolytic anemia leading to pallor, jaundice, and fatigue.
- Increased susceptibility to infections, particularly encapsulated bacteria.
- Organ damage, including stroke, acute chest syndrome, splenic sequestration, and renal dysfunction.
- Delayed growth and development in children.
- Leg ulcers, particularly in adults.
- Retinopathy and vision impairment.
Signs & Symptoms
Symptoms (Patient-Reported)
- Severe pain episodes (crises) in various parts of the body.
- Shortness of breath and fatigue.
- Yellowing of the skin and whites of the eyes (jaundice).
- Swelling of hands and feet (dactylitis) in infants.
- Frequent infections and fever.
- Delayed growth and puberty.
- Vision problems.
Signs (Clinician-Observed)
- Pallor (pale skin and mucous membranes).
- Jaundice.
- Splenomegaly (enlarged spleen) in early childhood, often followed by autosplenectomy in adults.
- Heart murmurs due to hyperdynamic circulation.
- Leg ulcers.
- Retinal hemorrhages or neovascularization.
Differential Diagnoses
| Condition | Distinguishing Feature |
|---|
| Thalassemias | Typically characterized by reduced globin chain synthesis, leading to microcytic, hypochromic anemia, rather than the presence of HbS and characteristic sickling. |
| Hereditary Spherocytosis | Results in spherically shaped red blood cells and hemolytic anemia, but lacks the sickle cell morphology and the underlying genetic defect of HbS. |
| Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency | Causes episodic hemolytic anemia triggered by oxidative stress, but red blood cells do not sickle and the underlying defect is enzymatic. |
| Autoimmune Hemolytic Anemia | Hemolysis is mediated by antibodies against red blood cells, leading to anemia but without the specific sickling phenomenon of SCD. |
| Sickle Cell Trait (HbAS) | Individuals are carriers and usually asymptomatic, with only a small proportion of HbS, and do not typically experience the severe complications of SCD. |
Red Flags — Seek Immediate Care
- Fever > 38.5°C (101.3°F) in a child with SCD, suggestive of overwhelming post-splenectomy infection (OPSI).
- Sudden onset of severe chest pain, shortness of breath, fever, and cough, concerning for acute chest syndrome.
- Neurological deficits (weakness, speech changes, seizure) indicating a stroke.
- Sudden drop in hemoglobin and enlarged spleen, suggestive of splenic sequestration.
- Priapism lasting more than 4 hours.
Key Investigations
- Complete Blood Count (CBC) with differential: reveals anemia (hemoglobin typically 6-10 g/dL), reticulocytosis, and characteristic sickle cells on peripheral smear.
- Hemoglobin Electrophoresis: the gold standard for diagnosing SCD, identifying the presence and proportion of HbS and other hemoglobin variants.
- Sickling Test: a qualitative test to detect the presence of HbS by inducing sickling under reduced oxygen tension.
- Liver and Renal Function Tests: to assess for organ damage.
- Echocardiogram: to evaluate for pulmonary hypertension.
- Transcranial Doppler (TCD) Ultrasound: to screen for stroke risk in children.
Management Overview
Management of SCD is multifaceted, focusing on preventing complications and treating acute events. Hydroxyurea is a cornerstone therapy that reduces the frequency of VOCs and acute chest syndrome by increasing fetal hemoglobin (HbF). Blood transfusions are vital for managing severe anemia, stroke prevention, and acute complications. Gene therapy and hematopoietic stem cell transplantation are emerging curative options for select patients.
Disclaimer: This article is for educational purposes only and does not constitute medical advice.
Always consult a qualified healthcare professional for diagnosis and treatment.
TruelyserMD does not replace clinical judgement.